SUBSCRIBE
SUBSCRIBE

Astria Therapeutics

NEWS
Business
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
New leaders and top executive roles were selected to guide biopharma and life science companies from Apertura Gene Therapy to CytoDyn, Vaccentis AG, Suvoda LLC, IN8bio and more.
July 14, 2022
 · 
9 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 04, 2023
April 4, 2023
 · 
1 min read
Business
Astria Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides a Corporate Update
March 22, 2023
 · 
12 min read
Business
Astria Therapeutics to Report Fourth Quarter/Full Year 2022 Financial Results and Recent Corporate Developments on Wednesday, March 22nd
March 8, 2023
 · 
1 min read
Genetown
Astria Therapeutics to Present at Upcoming Oppenheimer 33rd Annual Healthcare Conference
March 6, 2023
 · 
1 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 02, 2023
March 2, 2023
 · 
1 min read
Genetown
Astria Therapeutics Presents Additional Data Supporting STAR-0215 Profile as a Long-Acting Preventative Therapy for Hereditary Angioedema at the 2023 American Academy of Allergy, Asthma, and Immunology Annual Meeting
February 24, 2023
 · 
7 min read
Genetown
Astria Therapeutics to Present New STAR-0215 Data at the 2023 American Academy of Allergy, Asthma, and Immunology Annual Meeting
February 21, 2023
 · 
6 min read
Drug Development
Astria Therapeutics Initiates ALPHA-STAR Phase 1b/2 Clinical Trial of STAR-0215 in People with HAE
February 8, 2023
 · 
7 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 02, 2023
February 2, 2023
 · 
1 min read
Genetown
Astria Therapeutics Announces Closing of Underwritten Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 19, 2022
 · 
2 min read
Load More